Adult fulminant subacute sclerosing panencephalitis: Pathological and molecular studies - A case report

Clinical Neuropathology

Volumn 28, Issue 3, 2009, Pages 213-218

  Souraud, J B ^a   Faivre, A ^a   Waku Kouomou, D ^b   Gaillard, T ^a   Aouad, N ^a   Meaudre, E ^a   Wild, F T ^b   Fouet, B ^a   Soulard, R ^a  

^a Military Teaching Hospital Sainte Anne   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Cowdry; Genotype C2; Inclusion bodies; Measles; Subacute sclerosing panencephalitis

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; PHENOBARBITAL; PHENYTOIN; VIRUS RNA;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN BIOPSY; CASE REPORT; CELL INCLUSION; CELL NUCLEUS INCLUSION BODY; CEREBROSPINAL FLUID ANALYSIS; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBACUTE SCLEROSING PANENCEPHALITIS; TONIC CLONIC SEIZURE; BRAIN; GENETICS; MEASLES VIRUS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; VIROLOGY;

BASE SEQUENCE; BRAIN; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SSPE VIRUS; SUBACUTE SCLEROSING PANENCEPHALITIS; YOUNG ADULT;

EID: 67650341230     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp28213     Document Type: Article

References (18)

1. Alla A, Liffick SL, Newton BR, Elaouad R, Rota PA, Bellini WJ. Genetic analysis of measles viruses isolated in Morocco. J Med Virol Nov. 2002; 68: 441-444.
2. Anlar B, Pinar A, Yasar Anlar F, Engin D, Ustaçelebi S, Kocagöz T, Us D, Akduman D, Yalaz K. Viral studies in the cerebrospinal fluid in subacute sclerosing panencephalitis. J Infect. 2002; 44: 176-180.
3. Burger PC, Scheithauer BW, Vogel FS. Surgical Pathology of the Nervous System and Its Coverings, 4th edition. Churchill: Livingstone; 2002. p. 114-131.
4. Beach TG, Walker DG, Sue LI, Newell A, Adler CC, Joyce JN. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J Neuropathol Exp Neurol. 2004; 63: 329-337.
5. Chung BH, Ip PP, Wong VC, Lo JY, Harding B. Acute fulminant subacute sclerosing panencephalitis with absent measles and PCR studies in cerebrospinal fluid. Pediatr Neurol. 2004; 31: 222-224.
6. Cowdry EV. The problem of intranuclear inclusion in virus diseases. Arch Path. 1934; 18: 527-542.
7. Croxson MC, Anderson NE, Vaughan AA, Hutchinson DO, Schroeder BA, Cluroe AD, Hyatt AD. Subacute measles encephalitis in an immunocompetent adult. J Clin Neurosci. 2002; 9: 600-604.
8. Dhib-Jalbut S, Liwnicz BH. Rapidly progressive subacute sclerosing panencephalitis: an ultrastructural and immunoperoxidase study. Eur Neurol. 1984; 23: 211-220.
9. Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J Feb. 2002; 78: 63-70.
10. Kouomou DW, Nerrienet E, Mfoupouendoun J, Tene G, Whittle H,Wild TF. Measles virus strains circulating in Central and West Africa: Geographical distribution of two B3 genotypes. J Med Virol. 2002; 68: 433-440.
11. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 2004; 5: 150-163.
12. Lamba W, Prichett W, Munoz D, Park DS, Woulfe JM. MPTP induces intranuclear rodlet formation in midbrain dopaminergic neurons. Brain Res. 2005; 1066: 86-91.
13. Lewandowska E, Lechowicz W, Szpak GM, Sobczyk W. Quantitative evaluation of intranuclear inclusions in SSPE: correlation with disease duration. Folia Neuropathol. 2001; 39: 237-241.
14. Malandrini A, Villanova M, Tripodi S, Palmeri S, Sicurelli F, Parrotta E, BertiG, Salvadori C, Cintorino M, Guazzi GC. Neuronal intranuclear inclusion disease: neuropathologic study of a case. Brain Dev. 1998; 20: 290-294.
15. PeBenito R, Naqvi SH, Arca MM, Schubert R. Fulminating subacute sclerosing panencephalitis. Clin Pediatr (Phila). 1997; 36: 149-154.
16. Riddell MA, Rota JS, Rota PA. Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras. Virol J. 2005; 2: 87.
17. Schneider-Schaulies S, Ter Meulen V.Pathogenic aspects of measles virus infections. Arch Virol Suppl 1999; 15: 139-158.
18. WHO. Update of the nomenclature for describing the genetic characteristics of wild-type measles virus : new genotypes and references strains. Wkly Epidemiol Rec. 2003; 78: 229-232.